Advances in wearable drug delivery, this conference will review the current trends in the market and highlight the latest technology in this fast growing area.
The first “wearable” drug delivery device was developed in the early 1960s, a backpack which delivered insulin to the wearer. Smaller, more conveniently wearable, syringe-drivers were developed over the following decades for delivery of insulin. These type of devices are now universally known as insulin pumps and the latest versions are stuck directly onto the skin and controlled wirelessly. Ambulatory syringe drivers and bladder pumps are also used for chemotherapy and analgesia.
From the 1980s onwards, wearable passive transdermal patches were developed for dosing a range of drugs such as hormones, analgesics, anti-hypertensives and nicotine to aid smoking cessation. Recently there has been emphasis on development of wearable pumps to deliver larger volumes of biologic drugs, which would be inconvenient to deliver by self-injection.
Why you should attend:
This conference will be beneficial to all those who are interested in learning about, developing or sourcing wearable drug delivery devices. This includes pharmaceutical, medical device and drug delivery companies both large and small. The conference will be of particular interest to R&D, technical, medical, clinical, operating and marketing functions at all levels of management within these organisations.
Chairman’s welcome and introduction
Emerging trends for novel drug delivery systems
Understanding the market for wearable large volume injectors
Assessing injection site pain
Challenges with high volume and high viscous drug formulations
Demand for large volume injectors
Advances in patch pump technology
Patch pumps and large volume injectors for volumes from 1 to 20 ml
Panel discussion: The challenges associated with large volume injectors
Review of day one
Enterprise connected health and wearable drug delivery
Advances in the fill and finish process for biotech products
Drug delivery solutions for advanced biologics
Challenges of medication delivery in acute and chronic care settings – Implications for delivery device design
Planned changes to the 11608 series of ISO standards and their implications for wearable injectors
Low power wireless for drug delivery applications
Panel discussion: Large volume injections: the opportunity for connected devices
This course qualifies for the following CPD programmes:
We do not currently have dates confirmed for this course; please contact us to be informed when it is scheduled; or to discuss running this course on an in-house basis for your staff.